je.st
news
Tag: a
Rules - Suspension of Benefits (Exhibit A)
2014-02-21 01:06:01| PortlandOnline
PDF Document, 69kbCategory: Proposed Rule Changes
Tags: a
rules
benefits
exhibit
Rules - IME (Exhibit A)
2014-02-21 01:01:22| PortlandOnline
PDF Document, 78kbCategory: Proposed Rule Changes
Rules - Application for Benefits (Exhibit A)
2014-02-21 01:00:50| PortlandOnline
PDF Document, 119kbCategory: Proposed Rule Changes
Tags: a
application
rules
benefits
PoL DC/DC Converters come in high-efficiency 12 and 20 A models.
2014-02-10 14:32:08| Industrial Newsroom - All News for Today
Respectively delivering up to 12 and 20 A, 20.32 x 11.43 x 8.55 mm OKL2-T/12 and 33.02 x 13.46 x 8.75 mm OKL2-T/20 offer 93%–95% typ conversion efficiency and come in inspectable Land Grid Array (iLGA) package that facilitates probing of all signal pads and visual inspection. Both non-isolated models have 2 variants that accommodate nominal 5 Vdc (2.4–5.5 Vdc) or 12 Vdc (4.5–14 Vdc) input range; 5 and 12 V models provide programmable output voltages from 0.6–3.63 Vdc and 0.69–5.5 Vdc. This story is related to the following:DC To DC Converters
Tags: a
models
pol
converters
Alnylam Initiates Phase 1 Clinical Trial with ALN-AT3, a...
2014-01-23 08:48:30| Biotech - Topix.net
Alnylam Pharmaceuticals , Inc. , a leading RNAi therapeutics company, announced today that it has initiated a Phase 1 study with ALN - AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin for the treatment of hemophilia and rare bleeding disorders .
Sites : [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] next »